These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 795437)

  • 1. [Results of a field study on the therapeutic value of aprotinin in traumatic shock (author's transl)].
    Schneider B
    Arzneimittelforschung; 1976; 26(8):1606-10. PubMed ID: 795437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Field study on the therapeutic value of trasylol in traumatic shock].
    Schneider B; Schnells G; Trentz O; Tscherne H
    Chirurg; 1976 Apr; 47(4):185-8. PubMed ID: 1085692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of aprotinin in acute myocardial infarction (clinical double-bind study (author's transl)].
    Beck OA; Vogt W; Ziem M; Hochrein H
    Dtsch Med Wochenschr; 1975 Jan; 100(4):137-41. PubMed ID: 1089521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of trasylol on some complications and serum activity in acute myocardial infarction (author's transl)].
    Wójcikiewicz O; Moczurad K; Malata A
    Przegl Lek; 1976; 33(5):555-63. PubMed ID: 781748
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of combined use of aprotinin and corticosteroid in traumatic shock rats (author's transl)].
    Kugimiya H; Suemori I
    Masui; 1978 May; 27(5):484-9. PubMed ID: 307073
    [No Abstract]   [Full Text] [Related]  

  • 6. [Trasylol R on the status of experimental shock (preliminary results)].
    Back N; Wilkens H; Munson AE; Steger R
    Rev Bras Med; 1968 Jun; 25(6):410-5. PubMed ID: 5304846
    [No Abstract]   [Full Text] [Related]  

  • 7. [Trasylol in the shock therapy. Its effects and their interpretation].
    Haberland GL; Koslowski L; Matis P
    Med Welt; 1972 Aug; 23(31):1049-56. PubMed ID: 4539608
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antishock effects of trasylol and its protective effects on open heart surgery (author's transl)].
    Suemori I; Yoshitake J
    Kokyu To Junkan; 1976 May; 24(5):441-6. PubMed ID: 1084005
    [No Abstract]   [Full Text] [Related]  

  • 9. [The pathophysiology of tourniquet shock].
    Rahmer H
    Fortschr Med; 1979 Aug; 97(29):1277-9. PubMed ID: 313360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Controlled therapeutic trial of aprotinin and glucagon in acute pancreatitis (author's transl)].
    Gauthier A; Gillet M; Di Costanzo J; Camelot G; Maurin P; Sarles H
    Gastroenterol Clin Biol; 1978 Oct; 2(10):777-84. PubMed ID: 365662
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of the tourniquet syndrome with Trasylol].
    Kristen H; Eigler FW; Stock W
    Langenbecks Arch Chir; 1969; 325():292-5. PubMed ID: 5309028
    [No Abstract]   [Full Text] [Related]  

  • 12. [Controlled study on trasylol in the treatment of acute pancreatitis].
    Trapnell JE; Rigby CC; Talbot CH; Duncan EH
    Med Welt; 1974 Dec; 25(50):2106-11. PubMed ID: 4613997
    [No Abstract]   [Full Text] [Related]  

  • 13. [Reduction of postoperative edema following isolated hyperthermic perfusion of the extremities with prophylactic administration of aprotinin. Preliminary results].
    Walther H; Aigner KR; Link KH; Helling HJ; Schwemmle K
    Arzneimittelforschung; 1985; 35(7):1065-9. PubMed ID: 2413870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis of post-traumatic pulmonary insufficiency by protease-inhibitor therapy with aprotinin: a clinical study.
    McMichan JC; Rosengarten DS; Philipp E
    Circ Shock; 1982; 9(2):107-16. PubMed ID: 6177441
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of the proteinase inhibitor (aprotinin) on the course of experimental burn shock].
    Rybák M; Petz R; Jańecek J; Petáková M
    Cas Lek Cesk; 1976 Sep; 115(35):1067-71. PubMed ID: 1086136
    [No Abstract]   [Full Text] [Related]  

  • 16. [Systemic enzyme therapy in the treatment and prevention of post-traumatic and postoperative swelling].
    Kamenícek V; Holán P; Franĕk P
    Acta Chir Orthop Traumatol Cech; 2001; 68(1):45-9. PubMed ID: 11706714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Double-blind study of Aprotininum (Trasylol) in the management of alcoholic delirium].
    Tacke B; Kempf H
    Int Pharmacopsychiatry; 1975; 10(1):37-41. PubMed ID: 1095511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Indications for proteinase-inhibitor therapy in surgery. Clinical study and animal experiments].
    Eckert P; Riesner K; Doehn M
    Med Welt; 1974 Dec; 25(51-52):2154-7. PubMed ID: 4613999
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of aprotinin (Trasylol) on aorta-coronary bypass graft patency.
    Bidstrup BP; Underwood SR; Sapsford RN; Streets EM
    J Thorac Cardiovasc Surg; 1993 Jan; 105(1):147-52; discussion 153. PubMed ID: 7678314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol).
    Bidstrup BP; Royston D; Sapsford RN; Taylor KM
    J Thorac Cardiovasc Surg; 1989 Mar; 97(3):364-72. PubMed ID: 2465457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.